$DGX
QUEST DIAGNOSTICS INC

2024 Q4 Form 10-Q Financial Statement

#000102207924000190 Filed on October 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $2.488B
YoY Change 8.41%
Cost Of Revenue $1.677B
YoY Change 8.83%
Gross Profit $811.0M
YoY Change 7.56%
Gross Profit Margin 32.6%
Selling, General & Admin $448.0M
YoY Change 17.89%
% of Gross Profit 55.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $125.0M
YoY Change 12.61%
% of Gross Profit 15.41%
Operating Expenses $448.0M
YoY Change 17.89%
Operating Profit $330.0M
YoY Change -3.51%
Interest Expense -$49.00M
YoY Change -219.51%
% of Operating Profit -14.85%
Other Income/Expense, Net -$34.00M
YoY Change -20.93%
Pretax Income $296.0M
YoY Change -1.0%
Income Tax $65.00M
% Of Pretax Income 21.96%
Net Earnings $226.0M
YoY Change 0.44%
Net Earnings / Revenue 9.08%
Basic Earnings Per Share $2.01
Diluted Earnings Per Share $1.99
COMMON SHARES
Basic Shares Outstanding 111.6M shares 111.3M shares
Diluted Shares Outstanding 113.0M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $764.0M
YoY Change 434.27%
Cash & Equivalents $764.0M
Short-Term Investments
Other Short-Term Assets $299.0M
YoY Change 44.44%
Inventory $184.0M
Prepaid Expenses
Receivables $1.376B
Other Receivables $0.00
Total Short-Term Assets $2.623B
YoY Change 44.52%
LONG-TERM ASSETS
Property, Plant & Equipment $2.093B
YoY Change 14.37%
Goodwill $8.605B
YoY Change 11.29%
Intangibles $1.716B
YoY Change 40.77%
Long-Term Investments $125.0M
YoY Change -3.85%
Other Assets $272.0M
YoY Change 82.55%
Total Long-Term Assets $13.47B
YoY Change 15.47%
TOTAL ASSETS
Total Short-Term Assets $2.623B
Total Long-Term Assets $13.47B
Total Assets $16.10B
YoY Change 19.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.313B
YoY Change 13.48%
Accrued Expenses $176.0M
YoY Change 12.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $603.0M
YoY Change 98.36%
Total Short-Term Liabilities $2.092B
YoY Change 29.3%
LONG-TERM LIABILITIES
Long-Term Debt $5.648B
YoY Change 43.13%
Other Long-Term Liabilities $891.0M
YoY Change 1.95%
Total Long-Term Liabilities $6.539B
YoY Change 648.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.092B
Total Long-Term Liabilities $6.539B
Total Liabilities $8.631B
YoY Change 246.35%
SHAREHOLDERS EQUITY
Retained Earnings $9.222B
YoY Change 5.87%
Common Stock $2.334B
YoY Change 1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.732B
YoY Change 3.54%
Treasury Stock Shares
Shareholders Equity $6.809B
YoY Change
Total Liabilities & Shareholders Equity $16.10B
YoY Change 19.38%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $226.0M
YoY Change 0.44%
Depreciation, Depletion And Amortization $125.0M
YoY Change 12.61%
Cash From Operating Activities $356.0M
YoY Change 71.98%
INVESTING ACTIVITIES
Capital Expenditures $106.0M
YoY Change 0.95%
Acquisitions $1.533B
YoY Change 76550.0%
Other Investing Activities -$1.527B
YoY Change 76250.0%
Cash From Investing Activities -$1.633B
YoY Change 1426.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.770B
YoY Change -2232.53%
NET CHANGE
Cash From Operating Activities 356.0M
Cash From Investing Activities -1.633B
Cash From Financing Activities 1.770B
Net Change In Cash 493.0M
YoY Change 2800.0%
FREE CASH FLOW
Cash From Operating Activities $356.0M
Capital Expenditures $106.0M
Free Cash Flow $250.0M
YoY Change 145.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Central Index Key
EntityCentralIndexKey
0001022079
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1387862
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Plaza Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Secaucus,
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07094
dei City Area Code
CityAreaCode
(973)
dei Local Phone Number
LocalPhoneNumber
520-2700
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value
dei Trading Symbol
TradingSymbol
DGX
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1541000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4865000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4647000000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
448000000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
380000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1304000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1235000000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
90000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81000000 usd
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-6000000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
2158000000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1953000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
6266000000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114000000 shares
CY2024Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
us-gaap Profit Loss
ProfitLoss
685000000 usd
us-gaap Profit Loss
ProfitLoss
703000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
686000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000000 usd
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
84000000 usd
CY2024Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
17000000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24000000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
24000000 usd
CY2023Q3 dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
236000000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Amendment Flag
AmendmentFlag
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111615181 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2488000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2295000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7251000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6964000000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1677000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000000 usd
us-gaap Profit Loss
ProfitLoss
685000000 usd
us-gaap Profit Loss
ProfitLoss
703000000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
36000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
41000000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
226000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
225000000 usd
us-gaap Net Income Loss
NetIncomeLoss
649000000 usd
us-gaap Net Income Loss
NetIncomeLoss
662000000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.79
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112000000 shares
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6287000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5930000000 usd
dei Document Type
DocumentType
10-Q
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-21000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58000000 usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity File Number
EntityFileNumber
001-12215
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Quest Diagnostics Inc
us-gaap Costs And Expenses
CostsAndExpenses
5969000000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
330000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
342000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
985000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
995000000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-49000000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-40000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-136000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-112000000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-109000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-102000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
296000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
299000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
876000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
893000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
205000000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18000000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
241000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
233000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
684000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
704000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
11000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
12000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
36000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
41000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
230000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
221000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
648000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
663000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
764000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
686000000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1376000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1210000000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
184000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
190000000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
299000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
286000000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2623000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2372000000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2093000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1816000000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
661000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
602000000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
8605000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7733000000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1716000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1166000000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
125000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
135000000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
272000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000000 usd
CY2024Q3 us-gaap Assets
Assets
16095000000 usd
CY2023Q4 us-gaap Assets
Assets
14022000000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1313000000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1359000000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
603000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
303000000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
176000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
153000000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2092000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1815000000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5648000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4410000000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
543000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
503000000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
891000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
876000000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
80000000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
76000000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2332000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2320000000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9222000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8825000000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
50000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
51000000 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4732000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4826000000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6809000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6307000000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
32000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
35000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6841000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6342000000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16095000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14022000000 usd
us-gaap Profit Loss
ProfitLoss
685000000 usd
us-gaap Profit Loss
ProfitLoss
703000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
358000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
330000000 usd
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
4000000 usd
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-39000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
61000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
140000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
86000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-102000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-231000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
31000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
23000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
870000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
745000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1781000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
611000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
302000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
336000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-37000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2046000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-947000000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1846000000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1703000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
302000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
1426000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
52000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
60000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
24000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
247000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
234000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
35000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
41000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-36000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1254000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
78000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-172000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
764000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6656000000 usd
CY2024Q3 dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
236000000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000000 usd
CY2024Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
3000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6841000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6342000000 usd
dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
681000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
252000000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
35000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61000000 usd
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
3000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6841000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
80000000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6463000000 usd
dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
699000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
241000000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
36000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
28000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6463000000 usd
us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span></div>    Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") work across the healthcare ecosystem to create a healthier world, one life at a time. The Company's diagnostic information services ("DIS") business provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, the diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. In the right hands and with the right context, the diagnostic insights can inspire actions that transform lives and create a healthier world. The Company provides services to a broad range of customers within its primary customer channels - physicians (including those associated with accountable care organizations and Federally Qualified Health Centers), hospitals, and patients and consumers. Other customers include health plans, employers, emerging retail healthcare providers, government agencies, pharmaceutical companies and other commercial clinical laboratories. The Company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company's large in-house staff of medical and scientific experts, including medical directors, scientific directors, genetic counselors and board-certified geneticists, provide medical and scientific consultation to healthcare providers and patients regarding the Company's tests and test results, and help them best utilize Quest Diagnostics' services to improve outcomes and enhance satisfaction. The Company's Diagnostic Solutions ("DS") group, which represents the balance of the Company's consolidated net revenues, includes the Company's risk assessment services business, which offers solutions for insurers, and the Company's healthcare information technology businesses, which offer solutions for healthcare providers and payers.
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
226000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
225000000 usd
us-gaap Net Income Loss
NetIncomeLoss
649000000 usd
us-gaap Net Income Loss
NetIncomeLoss
662000000 usd
CY2024Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
1000000 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
4000000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
225000000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
223000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
646000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
658000000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114000000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.79
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
7000000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
1000000 usd
us-gaap Restructuring Charges
RestructuringCharges
21000000 usd
us-gaap Restructuring Charges
RestructuringCharges
17000000 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000000 usd
CY2024Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
7000000 usd
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1000000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
21000000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
22000000 usd
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
1800000000 usd
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
6000000 usd
CY2023Q4 dgx Prepayments To Acquire Businesses Net Of Cash Acquired
PrepaymentsToAcquireBusinessesNetOfCashAcquired
30000000 usd
dgx Prepayments To Acquire Businesses Net Of Cash Acquired
PrepaymentsToAcquireBusinessesNetOfCashAcquired
30000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
872000000 usd
CY2024Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
590000000 usd
CY2024Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2588000000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2461000000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7700000000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7471000000 usd
CY2024Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
222000000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
225000000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
647000000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
661000000 usd
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.97
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.99
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
5.78
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
5.87
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.95
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.97
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
5.72
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
5.79
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
641000000 usd
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6300000000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4600000000 usd
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37000000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
25000000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
6251000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4713000000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
603000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
303000000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5648000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4410000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
601000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
501000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
401000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1000000 usd
CY2024Q3 dgx Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
4789000000 usd
CY2024Q3 dgx Long Term Debt Maturities Gross
LongTermDebtMaturitiesGross
6293000000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
11000000 usd
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37000000 usd
CY2024Q3 dgx Debt Instrument Fair Value Basis Adjustment Attributable To Hedged Debt
DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt
-6000000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
6251000000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
603000000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5648000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1000000000 usd
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1000000.0 shares
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1100000 shares
CY2024Q3 us-gaap Depreciation
Depreciation
93000000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
84000000 usd
us-gaap Depreciation
Depreciation
268000000 usd
us-gaap Depreciation
Depreciation
249000000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
90000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81000000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
125000000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
358000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
330000000 usd
CY2024Q3 us-gaap Interest Expense Operating
InterestExpenseOperating
58000000 usd
CY2023Q3 us-gaap Interest Expense Operating
InterestExpenseOperating
41000000 usd
us-gaap Interest Expense Operating
InterestExpenseOperating
154000000 usd
us-gaap Interest Expense Operating
InterestExpenseOperating
117000000 usd
CY2024Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9000000 usd
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1000000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18000000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5000000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-49000000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-40000000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-136000000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-112000000 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
62000000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
17000000 usd
us-gaap Interest Paid Net
InterestPaidNet
167000000 usd
us-gaap Interest Paid Net
InterestPaidNet
97000000 usd
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
61000000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
99000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
179000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
233000000 usd
CY2024Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
35000000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
27000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
35000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
27000000 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
84000000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
81000000 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
84000000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
81000000 usd
CY2024Q3 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1725000000 usd
CY2023Q3 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
2000000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
2014000000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
736000000 usd
CY2024Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
142000000 usd
CY2023Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
183000000 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
36000000 usd
CY2024Q3 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
1583000000 usd
CY2023Q3 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
2000000 usd
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
1831000000 usd
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
700000000 usd
CY2024Q3 dgx Merger Consideration Paid Payable Net
MergerConsiderationPaidPayableNet
0 usd
CY2023Q3 dgx Merger Consideration Paid Payable Net
MergerConsiderationPaidPayableNet
0 usd
dgx Merger Consideration Paid Payable Net
MergerConsiderationPaidPayableNet
0 usd
dgx Merger Consideration Paid Payable Net
MergerConsiderationPaidPayableNet
-88000000 usd
CY2024Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1583000000 usd
CY2023Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2000000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1831000000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
612000000 usd
CY2024Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
50000000 usd
CY2023Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
50000000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1000000 usd
CY2024Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1533000000 usd
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1781000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
611000000 usd
CY2024Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
42000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
120000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
143000000 usd
dgx Increase Decrease In Bank Overdrafts
IncreaseDecreaseInBankOverdrafts
-22000000 usd
dgx Increase Decrease In Bank Overdrafts
IncreaseDecreaseInBankOverdrafts
15000000 usd
CY2024Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
166000000 usd
CY2023Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
173000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2488000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2295000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7251000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6964000000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
330000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
342000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
985000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
995000000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-109000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-102000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
296000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
299000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
876000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
893000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
205000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18000000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
237000000 usd
us-gaap Profit Loss
ProfitLoss
685000000 usd
us-gaap Profit Loss
ProfitLoss
703000000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
36000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
41000000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
226000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
225000000 usd
us-gaap Net Income Loss
NetIncomeLoss
649000000 usd
us-gaap Net Income Loss
NetIncomeLoss
662000000 usd
CY2024Q3 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
CY2023Q3 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
CY2024Q3 dgx Percentageof Net Accounts Receivable
PercentageofNetAccountsReceivable
1
CY2023Q4 dgx Percentageof Net Accounts Receivable
PercentageofNetAccountsReceivable
1
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001022079-24-000190-index-headers.html Edgar Link pending
0001022079-24-000190-index.html Edgar Link pending
0001022079-24-000190.txt Edgar Link pending
0001022079-24-000190-xbrl.zip Edgar Link pending
dgx-20240930.htm Edgar Link pending
dgx-20240930.xsd Edgar Link pending
dgx09302024ex22.htm Edgar Link pending
dgx09302024ex311.htm Edgar Link pending
dgx09302024ex312.htm Edgar Link pending
dgx09302024ex321.htm Edgar Link pending
dgx09302024ex322.htm Edgar Link pending
dgx093024ex31.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
dgx-20240930_cal.xml Edgar Link unprocessable
dgx-20240930_def.xml Edgar Link unprocessable
dgx-20240930_lab.xml Edgar Link unprocessable
dgx-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dgx-20240930_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending